Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 9, Pages e107592
Publisher
Public Library of Science (PLoS)
Online
2014-09-20
DOI
10.1371/journal.pone.0107592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
- (2013) Salvatore Petta et al. BMC INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease
- (2013) Daniel Felmlee et al. Viruses-Basel
- Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner
- (2012) Paul J. Clark et al. HEPATOLOGY
- Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice
- (2012) Claus Niederau WORLD JOURNAL OF GASTROENTEROLOGY
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment
- (2011) K. Neukam et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis
- (2011) A. Probst et al. JOURNAL OF VIRAL HEPATITIS
- Optimal therapy in hepatitis C virus genotypes 2 and 3 patients
- (2011) Salvatore Petta et al. LIVER INTERNATIONAL
- Treatment of patients with genotype 3 chronic hepatitis C- current and future therapies
- (2011) Shiv K. Sarin et al. LIVER INTERNATIONAL
- Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C
- (2011) Arun J. Sanyal LIVER INTERNATIONAL
- Hepatitis C testing and treatment among active drug users in Amsterdam
- (2010) Catharina E.A. Lindenburg et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
- (2010) Stephen A. Harrison et al. HEPATOLOGY
- Associations between serum lipids and hepatitis C antiviral treatment efficacy
- (2010) Darmendra Ramcharran et al. HEPATOLOGY
- Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection
- (2010) C. Pedersen et al. JOURNAL OF VIRAL HEPATITIS
- Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance
- (2010) A. D. Martinez et al. JOURNAL OF VIRAL HEPATITIS
- Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis
- (2009) Serena Slavenburg et al. ANTIVIRAL THERAPY
- Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up
- (2009) Kathleen E. Corey et al. HEPATOLOGY
- Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses
- (2009) Y. Inoue et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C virus hijacks host lipid metabolism
- (2009) Gulam H. Syed et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis
- (2008) A. ANDRIULLI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients: Randomized Comparison of Direct Observed Therapy and Self-Administration
- (2008) Herbert L. Bonkovsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection
- (2008) Alessandra Mangia et al. HEPATOLOGY
- Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
- (2008) Martin Lagging et al. HEPATOLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study
- (2008) Patrice Cacoub et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now